Close Menu

LifeCodexx

Several new laboratories started to offer NIPT locally in 2015, and some providers have been shifting to less-expensive non-NGS platforms. 

Prices in Germany for noninvasive prenatal testing have plummeted over the last year, driven by competition and process improvements.

OKP will pay for testing if standard first trimester screening indicates a risk higher than 1:1000 for trisomies 21, 18, or 13.

The new test promises lower cost, faster turnaround time, and easier implementation than current NIPT, which rely on next-generation sequencing or microarray analysis.

NEW YORK (GenomeWeb) − Competition for non-invasive prenatal testing in Germany is heating up, with Illumina announcing this week that it has teamed up with a German diagnostic laboratory and other European labs to transfer Verinata's test technology to those countries, and LifeCodexx saying last

LifeCodexx's PrenaTest for noninvasive detection of fetal anueploidies is now available for use in multiple pregnancies. It can also be used following fertility treatment, such as in vitro fertilization or egg donation after the 9th week of gestation.

GATC Biotech subsidiary LifeCodexx has launched a new version of its noninvasive fetal aneuploidy test, PraenaTest Express, that has a turnaround time of one week.

GATC Biotech subsidiary LifeCodexx has updated its noninvasive sequencing-based PrenaTest for fetal trisomies so that it can be performed in high-risk pregnancies as early as nine weeks.

As sequencing-based non-invasive prenatal testing for chromosomal abnormalities is making its way into the clinic, with tens of thousands of tests being administered in the US alone last year, researchers are thinking about ways for integrating NIPT with existing screening progra

The University of Washington and Seattle Cancer Care Alliance have launched UW-Onco-Plex, a sequencing-based test to help guide treatment for cancer patients.

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.